Journal of Physical Chemistry & Biophysics
Open Access

Computational Biophysics Significance in the Protein-Ligand Integration for Molecular Docking

Ali Abishik^{* *}Correspondence: Ali Abishik, Department of Biophysics, University of Abuja, Giri, PMB 117, Abuja, Nigeria, Email:

Author info »

Description

Numerical algorithms have been used in computational biophysics to investigate the fundamental properties of biological occurrences and processes. It allows predicting resolutions to theoretical biophysical problems that lack closed-form solutions as well as modeling systems in which experiments are deemed unattainable. One of the fundamental issues in biophysics is accurately defining protein-ligand binding at the molecular level, which has enormous consequences in practical and basic research in areas such as drug design and enzyme engineering. Computer simulations, particularly molecular in silico technologies, are becoming increasingly popular in order to gain such precise understanding [1]. Protein-ligand interactions are an essential precursor for signal transduction, immunoreaction, and gene regulation in this case. Protein-ligand interactions are critical for understanding biological control mechanisms and providing a theoretical foundation for designing and discovering new therapeutic targets. The molecular interactions of proteinligand docked using AutoDock 4.2 programme were recently published.

As energy optimization algorithms, hybrid algorithm of random drift particle swarm optimization, local search, and the classic Lamarckian Genetic Algorithm (LGA) have been thoroughly examined with in AutoDock 4.2 programme. To understand the molecular mechanics of protein-ligand interactions, the best conformations of each docking technique were subjected to Molecular Dynamic (MD) simulations. The structural changes during the complex unfolding, the interactions of salt bridges and hydrogen bonds in the docking region, and the binding energy between the protein receptors and ligands. The comparison of these complexes reveals that the two docking technologies have different protein-ligand interactions [2]. This demonstrates the importance of salt bridge and hydrogen bond interactions in protein-ligand stability. The purpose of this research was to extract the deterministic aspects of docking contacts from their dynamic properties, which is critical for understanding biological activities and establishing which amino acid residues are important for docking interactions. The identification of protein-ligand interaction networks on a proteome-wide dimension is critical for a broad range of biological concerns, including coupling molecular functions to physiological processes and developing safe and effective therapies. Recent protein-ligand interaction studies have demonstrated that protein targets with completely distinct pharmacology can bind to small molecule medicines with similar properties. Drug promiscuity is a frequent phenomenon across the proteome, according to large-scale mapping of polypharmacology interactions. It was discovered that around 35% of known medicines were active against multiple targets. Furthermore, a considerable proportion of promiscuous chemicals (about 25%) have been found to have activity in various gene families. For modern drug research, such drug promiscuity brings both opportunities and challenges [3]. Chemogenomics is a novel field that aims to systematically identify target associations based on the structural and biological similarities of their ligands [4].

A protein's three-dimensional structure is critical for understanding biological processes at the molecular level. Protein-ligand binding sites and their interactions with binding partners generate strong structural-functional correlations, making them crucial for solving a variety of fundamental and practical biological problems. Protein-ligand binding sites give not only crucial information in clarifying the links between evolution, structure, and function, but also help with medication development. Such sites can be used to find and validate therapeutic targets, priorities and refine drug leads, rationalize small molecule screening and docking, direct medicinal chemistry efforts, and computationally evaluate ADME characteristics of preclinical compounds. It is vital to create a sensitive and robust algorithm that can detect and describe the ligand binding sites of proteins on a proteome-wide scale in order to draw knowledge about the ligand binding site from the continuously expanding amount of structural data [5].

Conclusion

Numerous biological processes, such as signal transduction, cell control, and immune response, rely heavily on protein-ligand interactions. In the physical sciences, studying protein-ligand interactions is still very significant. Different docking methods cause differences in protein-ligand complex architecture. In this post, researchers primarily focus on examining protein-ligand binding interactions, particularly the divergence of proteinligand interactions, which can help us, understand and address crucial concerns such as binding affinity and specificity variety. A chemical systems biology approach, which systematically explores protein-ligand interactions on a genome-wide scale and incorporates them into biological pathways, will provide us with valuable clues as to the molecular basis of cellular function through a combination biophysical computational simulation. Simultaneously, it will aid in the transition from the traditional single-target, single-drug drug discovery paradigm to a new multitarget, multi-molecule paradigm.

References

1. Plattner N, Noé F. Protein conformational plasticity and complex ligand-binding kinetics explored by atomistic simulations and Markov models. Nat Commun. 2015;6(1):1-10.

   [Crossref] [Google Scholar] [PubMed]

2. Abel R, Mondal S, Masse C, Greenwood J, Harriman G, Ashwell MA, et al. Accelerating drug discovery through tight integration of expert molecular design and predictive scoring. Curr Opin Struct Biol. 2017;43:38-44.

   [Crossref] [Google Scholar] [PubMed]

3. Kuhn M, Campillos M, González P, Jensen LJ, Bork P. Large-scale prediction of drug-target relationships. FEBS Lett. 2008;582(8):1283-1290.

   [Crossref] [Google Scholar] [PubMed]

4. Rognan D. Chemogenomic approaches to rational drug design. Br J Pharmacol. 2007;152(1): 38-52.

   [Crossref] [Google Scholar] [PubMed]

5. Xie L, Bourne PE. A robust and efficient algorithm for the shape description of protein structures and its application in predicting ligand binding sites. BMC Bioinformat. 2007;8(4):1-13.

   [Crossref] [Google Scholar] [PubMed]